Author: Jay Herson
Edition: 1
Publisher: Chapman and Hall/CRC
Binding: Hardcover
ISBN: 1420070371
Data and Safety Monitoring Committees in Clinical Trials (Chapman & Hall/CRC Biostatistics Series)
Focusing on the practical clinical and statistical issues that arise in pharmaceutical industry trials, this book summarizes the author’s experience in serving on many data monitoring committees (DMCs) and in heading up a contract research organization that provided statistical support to nearly seventy-five DMCs. Medical books Data and Safety Monitoring Committees in Clinical Trials . Medical books Data And Safety Monitoring Committees In Clinical Trials By Jay Herson Hardc. Store Search search Title, ISBN and Author Data and Safety Monitoring Committees in Clinical Trials by Jay Herson Estimated delivery 3-12 business days Format Hardcover Condition Brand New Focuses on the practical clinical and statistical issues that arise in pharmaceutical industry trials. This book explains the difference in DMC operations between the pharmaceutical industry and National Institutes of Health (NIH)-sponsored trials. It also how physicians think differently about safety data th
Download link for Data and Safety Monitoring Committees in Clinical Trials (Chapman & Hall CRC Biostatistics)
Store Search search Title, ISBN and Author Data and Safety Monitoring Committees in Clinical Trials by Jay Herson Estimated delivery 3-12 business days Format Hardcover Condition Brand New Focuses on the practical clinical and statistical issues that arise in pharmaceutical industry trials. This book explains the difference in DMC operations between the pharmaceutical industry and National Institutes of Health (NIH)-sponsored trials. It also how physicians think differently about safety data th
Taylor & Francis Ltd | 2009 | 191 pages | ISBN-13: 9781420070378 | ISBN-10: 1420070371 | You save 15%
Focusing on the practical clinical and statistical issues that arise in pharmaceutical industry trials, this book summarizes the author's experience in serving on many data monitoring committees (DMCs) and in heading up a contract research organization that provided statistical support to nearly seventy-five DMCs. It explains the difference in DMC operations between the pharmaceutical industry and National Institutes of Health (NIH)-sponsored trials. Leading you through the types of reports for adverse events and lab values, the author presents the statistical requirements of data monitoring c
Focusing on the practical clinical and statistical issues that arise in pharmaceutical industry trials, this book summarizes the author's experience in serving on many data monitoring committees (DMCs) and in heading up a contract research organization that provided statistical support to nearly seventy-five DMCs. It explains the difference in DMC operations between the pharmaceutical industry and National Institutes of Health (NIH)-sponsored trials. Leading you through the types of reports for adverse events and lab values, the author presents the statistical requirements of data monitoring c
Medical Book Data and Safety Monitoring Committees in Clinical Trials
It explains the difference in DMC operations between the pharmaceutical industry and National Institutes of Health (NIH)-sponsored trials. Leading you through the types of reports for adverse events and lab values, the author presents the statistical requirements of data monitoring committees and gives advice on how statisticians can best interact with physician members of these committees. He also shows how physicians think differently about safety data than statisticians, proving that both views are needed.
